Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.03.19
第三届董事会第八次聚会决议通告
2015.03.19
关于设立工业并购基金的通告
2015.03.17
关于公司使用自有资金购置低危害理工业品的希望通告
2015.02.28
2014年度业绩快报
2015.02.17
第三届监事会第五次聚会决议通告
2015.02.17
第三届董事会第七次聚会决议通告
2015.02.17
华英证券有限责任公司关于公司使用节余召募资金永世增补流动资金的专项核查意见
2015.02.17
关于使用节余召募资金永世增补流动资金的通告
2015.02.17
关于公司使用自有资金购置低危害理工业品的通告
2015.02.17
关于向银行申请授信的通告
第一页
上一页
101
102
103
104
105
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】